Health
Biotech Advances in Cancer Treatment
Two studies highlight advancements in cancer treatment. Enliven Therapeutics' leukemia drug shows promise, while synthetic lethality approaches could trigger biotech mergers and acquisitions.
Coverage timeline — 2 articles
STAT News
Proving out a "synthetic lethality" approach can help treat cancer will take a lot more work. It also might trigger some creative deal-making.
2026-06-11 12:05 UTC
STAT News
A targeted drug from Enliven Therapeutics induced molecular responses in nearly half of patients with advanced leukemia, new data show.
2026-06-11 12:05 UTC